CARGO Therapeutics | LinkedIn (original) (raw)

Biotechnology Research

San Carlos, California 14,372 followers

Outsmarting Cancer to Deliver More Cures

About us

CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients. In addition, far too many patients are unable to access these potentially curative therapies due to other challenges, including manufacturing, supply constraints, slow turnaround time and reimbursement hurdles. The team at CARGO is intensely focused on pursuing novel solutions to achieve better cancer treatment outcomes and experiences.

Industry

Biotechnology Research

Company size

51-200 employees

Headquarters

San Carlos, California

Type

Privately Held

Founded

2021

Locations

Employees at CARGO Therapeutics

Updates

Join now to see what you are missing

Join now

Similar pages

Browse jobs

Funding